CMIS INVEST IVS: Financial statements 2019
CVR: 38132776
CMIS INVEST IVS (CVR 38132776) has filed annual accounts for 2019. In 2019, the company reported a net result of DKK -3,815 compared with DKK 8,884 the year before. Equity amounted to DKK 7,039. The solvency ratio was 24.7%.
- Profit/Loss
- -3,815 kr.
- Equity
- 7,039 kr.
- Total Assets
- 28,462 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2019 | - | - | -4 t. | 7 t. | - |
| 2018 | - | - | 9 t. | 10 t. | - |
| 2017 | 0 | 0 | 0 | 2 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2019
CMIS INVEST IVS has published its annual report for 2018. The net result was DKK 8,884.
As of March 3, 2019, Carl Magnus Illum Smed is registered as adm. dir. of CMIS INVEST IVS.
As of March 3, 2019, Helle Illum Vendler has stepped down as director of CMIS INVEST IVS.
About CMIS INVEST IVS
CMIS INVEST IVS was a Danish company of the type Iværksætterselskab based in Karlslunde, founded in 2016 and dissolved in 2022. The company was registered under the industry Ikke-finansielle holdingselskaber. In 2020, the company reported a net result of DKK -14,456 compared with DKK -3,815 the year before. Equity amounted to DKK 1,875.
